Neo Ivy Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,545
Closed -$2.41M 471
2025
Q4
$2.41M Buy
+53,545
New +$2.48M 0.38% 106
2022
Q4
Sell
-190
Closed -$8K 512
2022
Q3
$8K Sell
190
-259
-58% -$12.8K 0.02% 332
2022
Q2
$22K Sell
449
-2,033
-82% -$99.2K 0.06% 296
2022
Q1
$128K Sell
2,482
-954
-28% -$49.2K 0.12% 275
2021
Q4
$203K Buy
+3,436
New +$197K 0.29% 139
2021
Q2
Sell
-54
Closed -$3K 581
2021
Q1
$3K Buy
+54
New +$2.97K ﹤0.01% 450

Other funds holding QGEN

Neo Ivy Capital Management's QGEN Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 53,545 shares — an estimated $2.41M sold.

Neo Ivy Capital Management first reported a position in QGEN in Q1 2021 and held it in 6 quarters. The position peaked at $2.41M in Q4 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Neo Ivy Capital Management reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 53,545 Qiagen shares in Q1 2026, an estimated $2.41M.
  • Neo Ivy Capital Management first reported a position in Qiagen in Q1 2021 and held it in 6 quarters.
  • Neo Ivy Capital Management's Qiagen position peaked at $2.41M in Q4 2025.
  • 346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.